BPA Call GSTFMGBPA090017-47QFCA19F0012

Award Date 12/10/18
Potential Completion Date 7/10/19
Potential Value $1.7M
Funding Federal Agency
Food and Drug Administration
Contracting Federal Agency
Assisted Acquisition Services FEDSIM
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Fairfax, VA 22033, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price Blanket Purchase Agreement (BPA) call awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Platinum Solutions, Inc., doing business as SRA International. The contract, which has a potential value of $1,995,892.00, is for an unspecified product or service delivery under the DARRTS program. The contract does not have a set-aside designation and was awarded on December 22, 2017, with a completion date of November 10, 2018. The...
This is a task order awarded under a single-award Blanket Purchase Agreement (BPA) to SRA International, a for-profit organization and self-certified small disadvantaged business. The purpose of this $3,497,069.00 task order is to provide the Food and Drug Administration (FDA) with critical modifications to enhance the functionality of the Document Archiving, Reporting, and Regulatory Tracking System (DARRTS) environment, ensuring business continuity. The task order is a labor-hour type contract...
This federal contract award is a Blanket Purchase Agreement (BPA) call order 32 under BPA number GSCTFMGBPA090017, awarded to General Dynamics Information Technology, Inc. (GDIT), a division of CSRA LLC doing business as SRA International, Inc. The BPA was originally awarded by the GSA FEDSIM program, but administrative responsibility was later transferred to GSA Region 9. The BPA call order, valued at $5,267,605, is for operations, maintenance, development and modernization services for the...
This is a $7,981,116.50 task order awarded to General Dynamics Information Technology, Inc. (GDIT) under the Multiple Award Schedule (MAS) contract. The task order is for operations and maintenance services for the Food and Drug Administration's (FDA) Document Archiving, Reporting, and Regulatory Tracking System (DARRTS). The work will be performed in Silver Spring, Maryland. GDIT has subcontracted portions of the work to several small businesses, including Exafluence Inc., Gartner, Inc., Sky...
This $2,714,517.49 firm fixed price task order was awarded by the Department of Health and Human Services Food and Drug Administration to DRT Strategies, Inc., a woman-owned small business and minority-owned contractor registered in SAM.gov since 2004. The task order was issued under the Information Technology Schedule 70 (IT-70) contract vehicle. DRT Strategies will provide steady state information technology services and solutions to the FDA's Center for Devices and Radiological Health...
This federal contract award, valued at $11,051,688.60, was granted to Precise Software Solutions, Inc., a minority-owned, self-certified small disadvantaged business, for the development and IT support services of the Food and Drug Administration's (FDA) Document Archiving Reporting and Regulatory Tracking System (DARRTS). The contract has a firm fixed-price delivery order structure and will run through October 23, 2025. Precise Software Solutions, headquartered in Rockville, Maryland, is a...
This is a $3,129,869.38 firm-fixed-price delivery order awarded to DRT Strategies, Inc. by the Food and Drug Administration (FDA) under the Strategic Partners Acquisition Readiness Contract (SPARC) IDIQ contract vehicle. The contract is for project management services to support the FDA's Long-Term Monitoring and Benchtop (LTMB) Systems Portfolio. DRT Strategies, a small disadvantaged, woman-owned business, has been awarded multiple contracts and task orders with the Department of Health and...
This is a Blanket Purchase Agreement (BPA) call order awarded by the Food and Drug Administration (FDA) to General Dynamics Information Technology, Inc. (GDIT), a subsidiary of CSRA LLC doing business as SRA International, Inc. The BPA, awarded under GSA Schedule 70 Information Technology, has a ceiling value of $9,224,164.75 and provides operations, maintenance, development, and modernization services for the FDA's Document Archiving, Reporting, and Regulatory Tracking System (DARRTS). The...
This is a federal contract award by the Department of Health and Human Services Food and Drug Administration (FDA) to DRT Strategies, Inc., a minority-owned, woman-owned small business. The contract is to provide information technology (IT) support services to the FDA's Office of Regulatory Affairs (ORA) Business Investments throughout all phases of the enterprise performance life cycle, including FSMA-related ORA programs. The contract has a potential value of $2,848,957.10 and was awarded on...
This federal contract award is a Blanket Purchase Agreement (BPA) call order from the Food and Drug Administration (FDA), a civilian federal agency, to General Dynamics Information Technology, Inc. (GDIT), a division of CSRA LLC. The contract is valued at $23,920,320.00 and provides operations, maintenance, development, and modernization services for the FDA's Document Archiving, Reporting, and Regulatory Tracking System (DARRTS). This BPA was initially awarded through the General Services...

This task order was awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Platinum Solutions, Inc. (also doing business as SRA International) to provide operations and maintenance (O&M) support for the FDA's DARRTS program. The award has a firm fixed price of $1,667,736.00 and a completion date of July 10, 2019. The contract was not set aside for any specific business type. The DARRTS program is a major FDA initiative, though further details about its scope and purpose are not provided.

Generated 3/21/24, 8:15 PM